首页> Cancer communications (London, England)> Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial.

Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yan,Zheng

第一单位： Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, P. R. China.

作者： Yan,Zheng ^[1] ; Guanghui,Liang ^[1] ; Dongfeng,Yuan ^[1] ; Xianben,Liu ^[1] ; Yufeng,Ba ^[1] ; Zimin,Qin ^[1] ; Sining,Shen ^[1] ; Zhenxuan,Li ^[1] ; Haibo,Sun ^[1] ; Baoxing,Liu ^[1] ; Quanli,Gao ^[2] ; Peng,Li ^[1] ; Zongfei,Wang ^[1] ; Shilei,Liu ^[1] ; Jianping,Zhu ^[1] ; Haoran,Wang ^[1] ; Haibo,Ma ^[1] ; Zhenzhen,Liu ^[3] ; Fei,Zhao ^[3] ; Jun,Zhang ^[3] ; He,Zhang ^[4] ; Daoyuan,Wu ^[4] ; Jinrong,Qu ^[5] ; Jie,Ma ^[6] ; Peng,Zhang ^[7] ; Wenjie,Ma ^[7] ; Ming,Yan ^[1] ; Yongkui,Yu ^[1] ; Qing,Li ^[8] ; Jiangong,Zhang ^[9] ; Wenqun,Xing ^[1]

作者单位： Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, P. R. China. ^[1] Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, P. R. China. ^[2] Department of Endoscopy, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, P. R. China. ^[3] Department of Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, P. R. China. ^[4] Department of Radiology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, P. R. China. ^[5] Department of Biobank, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, P. R. China. ^[6] Department of Strategic Development, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan, P. R. China. ^[7] Department of Statistics, LinkDoc Technology Co., Ltd, Beijing, P. R. China. ^[8] Department of Cancer Epidemiology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, P. R. China. ^[9]

关键词 esophageal squamous cell carcinoma minimally invasive esophagectomy neoadjuvant chemotherapy neoadjuvant immunochemotherapy survival